
Addus HomeCare Corporation: stock overview
Price
$123.00
November 13, 2026Market cap $2.3B
What Ploutos Investor adds for Addus HomeCare
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
In short
Addus HomeCare had revenue of $1.5B over the last 12 months and net income of $111M, a net margin of 7.4%. Revenue grew by 13.2% a year on average over the last 5 years. At $123.00 the shares trade at a P/E of 20.5, against a median of 29.6 over the last 5 fiscal years. It holds more cash than debt, by $77M. It pays no dividend.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $2.3B
- 18.52M shares
- P/E
- 20.5
- Today20.5Median29.6
- Revenue, 12 months
- $1.5B
- +13.2% a year over 5 years
- Net margin
- 7.4%
- 2025: 6.7%, above 79% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+15.9% a year over 2 years
Fiscal years in figures
ADUS's revenue, profit, cash flow and dividend with each year-end price, from 2016 to 2022, 7 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $2.0B
- $2.3B
- Enterprise value
- $2.2B
- P/E 3-year median: 24.2
- 20.5
- EV / EBIT
- 14.2
- EV / Revenue
- 1.5
- P/B 3-year median: 2.1
- 1.9
- FCF yield 3-year median: 5.2%
- 6.3%
- Earnings yield 3-year median: 4.1%
- 4.9%
Profitability
- Gross margin
- 32.3%
- Operating margin
- 10.3%
- Net margin 3-year median: 6.4%
- 7.4%
- ROIC
- 9.6%
- ROIC, 5-year average
- 7.6%
- ROE
- 10.0%
Growth
- Revenue, yearly change
- +23.2%
- EPS, yearly change
- +23.4%
- FCF, yearly change
- -6.0%
- Revenue, average a year
- +13.2%
- EPS, average a year
- +20.2%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $98M
- Total debt
- $67M
- Of which operating leases
- $45M
- Net cash
- $77M
- Net debt / EBITDA
- -0.5x
- Interest cover
- 19.7x
- Current ratio
- 1.64
Balance sheet of September 30, 2026.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- –
- Total returned
- 0.00%
- Shares, yearly change
- +1.9%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).
Gross margin
32.5%
Above 42% of the 25 companies in its industry, and 43% of all.
Operating margin
9.7%
Above 75% of the 62 companies in its industry, and 63% of all.
Net margin
6.7%
Above 79% of the 68 companies in its industry, and 57% of all.
ROE
8.8%
Above 63% of the 58 companies in its industry, and 56% of all.
ROA
6.7%
Above 80% of the 69 companies in its industry, and 79% of all.
Revenue growth
23.2%
Above 76% of the 68 companies in its industry, and 84% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- Addus HomeCare Corp
- CIK
- 1468328
- Exchange
- NASDAQ
- Industry (SIC)
- 8082 · Services-Home Health Care Services
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 18.52M
Other companies: Healthcare
The largest companies of the same sector, each with its own page.
- LLYEli Lilly and Company+0,00%Compare with ADUS
- JNJJohnson & Johnson+0,00%Compare with ADUS
- ABBVAbbVie+0,00%Compare with ADUS
- UNHUnitedHealth+0,00%Compare with ADUS
- MRKMerck & Company+0,00%Compare with ADUS
- AMGNAmgen+0,00%Compare with ADUS
- TMOThermo Fisher Scientific+0,00%Compare with ADUS
- ABTAbbott Laboratories+0,00%Compare with ADUS
The full analysis
What do Addus HomeCare's filings show?
These are Addus HomeCare's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is ADUS's market cap?
Addus HomeCare Corporation's market cap is $2.3B, at a price of $123.00 on November 13, 2026 and 18.52M shares.
What is ADUS's P/E?
ADUS's P/E is 20.5, on earnings per share of $6.01 over the last 12 months. The median over the last 5 fiscal years was 29.6.
How much revenue does ADUS have?
Addus HomeCare had revenue of $1.5B over the last 12 months. Over the last 5 years it changed by +13.2% a year on average.
Does ADUS pay a dividend?
No. Addus HomeCare paid no regular dividend over the last 12 months.
Where do the figures come from?
From Addus HomeCare Corporation's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.